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Potential Reproductive and Postnatal
Morbidity from Exposure to Polychlorinated
Biphenyls: Epidemiologic Considerations
by Walter J. Rogan,* Beth C. Gladen* and Allen J. WiIcox*
There is both laboratory and epidemiologic evidence that PCBs are toxic to several phases of
reproduction. Workplace exposure is an important but small partoftheexposuretothesecompounds, since
most ofthe population has detectable levels in blood orfat. Studies in the general population on PCBs and
reproduction have not been done. Some studies in workers are underway, and in epidemic PCB poisonings,
small babies with a distinct clinical syndrome are seen. We review some of the laboratory and
epidemiologic data and the methods available forstudar of reproduction in humans; study of any highly
exposed group should be done and studies of spontaneous abortion, birth weight and certain congenital
anomalies should look for an effect of PCBs.
Introduction
Successful human reproduction is a complex cycle
that can be broken arbitrarily into stages: conception,
the carriage ofthe fetus to term, the birth of a normal
baby, post-natal nurturance, and normal growth and
development. This cycle is closed with its reiteration by
the offspring. We regard interference with any ofthese
processes as amorbid event, evenwhenclinical illnessis
not apparent. There is evidence both from outbreaks of
human illness and from laboratory experiments that
polychlorinated biphenyls (PCBs) or chemical com-
pounds very similar to them can disrupt most of the
phases ofreproduction; whether they do so at the levels
of exposure commonly encountered in the general
population or in the workplace is not known.
We consider here the available epidemiologic data
relatingPCBs toreproduction. Wealsoconsider some of
the epidemiologic methods for study of reproductive
morbidity. Since the emphasis here is on a particular
exposure, the "natural" methods ofstudy are ofpopula-
tions who are surveyed for exposure and illness, or of
cohorts whose exposure is documented and who are
followed to see what illnesses they develop. However,
much ofwhat is known about the toxicity ofPCBs has
come from the study ofepidemics, in which sick people
were investigated and found to have been poisoned.
Thus we will discuss the case-control approach where it
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seems useful. Details of study feasibility and the large
experimental literature on PCBs are beyond the scope
ofthispaper, butafewcommentsarise onboth. We note
first, though, the difficult problem of studying a group
of chemicals that have become sufficiently widespread
in the enviroment that population exposure, in the
sense of detectable residues in body tissues, is almost
universal.
Use, Spread, and Human Exposure
Over 800 million tons of PCBs were produced and
distributed worldwide from their introduction in the
1930s until restrictive regulations in the 1970s (1).
Besides closed applications in heavy transformers,
PCBs were also the oily pigment suspension agent in
carbonless copy paper, were part ofmicroscope immer-
sion oil, were in ballasts and capacitors in consumer
electrical goods, and were a vehicle for application of
pesticides. Exposure of workers to PCBs represents a
small, albeit important, part ofthe human exposure to
these compounds. More widespread exposure has re-
sulted from the dispersion or disposal ofthese goods in
ways, suchasrecyclingcarbonlesscopypaper, that were
not recognized as unsuitable or hazardous. PCBs are
very stable; they resist both physical degradation by
agents in the environment and metabolic degradation
by organisms.
Like DDT (2), PCBs bioconcentrate. Environmental
levels in water are quite low; single-celled organisms
will come into a steady state with them. However,ROGAN, GLADEN AND WILCOX
predators store essentially all that they ingest over a
lifetime, and thus all organisms other than primary
consumers encounter levels above ambient ones. An
ecologic rule of thumb is that concentrations increase
about one orderofmagnitude perlinkupthefood chain.
Hence, fish-eating birds will have tissue levels thou-
sands of times higher than the sediment levels in the
water where they prey. Man lives quite high on the food
chain, and there is monitoring data available to show
that PCBs are detectable at high prevalence in unse-
lected groups ofpeople (3-5). This is likely to be due to
low level contamination ofthe food supply, particularly
of predators like big fish (6).
Human vulnerability to contaminated food comes not
only from our position on the food chain, but also from
the complexity of the systems used to grow and dis-
tribute foodstuffs. Accidental contamination offood from
wrappers made fromrecycled paper (7) and ofmeat and
dairyproductscontaminated fromleakingmachinery(8)
have occurred in the past. Most notable are the two
major outbreaks of Yusho, which were both caused by
contaminated oil from leaking heat process machinery
(9). Even organic gardeners are at risk; an incident in
Bloomington, Indiana, involved the use ofsewage sludge
contaminated with PCBs as organic material incorpo-
rated into garden soil (10). The sole remaining dietary
source that is regularly heavily contaminated is sport
fish caught from polluted waters. However, continued
human exposure from other sources is certain. This is
due to the large amounts of PCBs in use, the gradual
turnover and disposal of machinery and other goods
containingthem, andthe difficulties encountered inhaz-
ardous waste handling in general.
Besidesdietary exposure, there are atleasttwo other
routes by which people could be appreciably exposed.
Because of the oily, adherent nature of PCBs, they
could be carried home on soiled workclothes. Although
there is not a clear example ofthis having happened for
PCBs, work clothes soiled with dioxin and brought
home have produced chloracne in the children ofwork-
ers (11); this vector is thus capable of producing
biologically active exposure, and good industrial hy-
gienepractices arewarranted. SincePCBs are dermally
absorbed, reproductively active workers or workers
with children should be aware of this route. Improper
waste disposal can produce direct exposure; in North
Carolina, 200 miles of roadside were contaminated by
dumped PCBs resembling Aroclor 1260, a heavily
chlorinated mixture. Women who lived on the road or
crossed it regularly had heavier congeners in their milk
more frequently than controls (12). Overall levels were
no higher and no illnesses have been reported.
It is thus difficult to speak of "exposed" and "un-
exposed" groups of people. Occupational exposure and
the exposure of heavy consumers of sport fish are
probably the highest, but these may well overlap with
exposure from accidents involving waste disposal or
food contamination. Thus any occupational study must
deal with the background of exposure that is usually
present. On the other hand, studies of general effects
on populations must confront ubiquitous, low level
exposures.
In addition, the congeneric composition of PCB
mixtures will differ, as willthe amount ofcontamination
by terphenyls, quatraphenyls and furans, depending on
the original source, the kind of use and the degree of
degradation. For example, the two outbreaks of Yusho
involved mixtures heavily contaminated with these
other chemicals, so it is not clear to what extent the
results observed there apply to other situations.
Pharmacology and Dose
PCBs are strongly lipophilic, and many ofthe conge-
ners are refractory to either metabolic breakdown or
the attachment ofamoietythatwould makethemwater
soluble. Since healthy human beings excrete virtually
no fat (except when lactating), the compounds accumu-
late in fatty tissue. There are few data on absorption,
distribution, and excretion ofPCBs in man; in general,
though, it is reasonable to assume that there are few
barriers to diffusion, thatthecompoundswilldissolvein
anyfat, and theywill thus be presentin agiven organ or
tissue in proportion to its fat content. These assump-
tions lead to a simple pharmacokinetic model: PCBs are
absorbed from the gastrointestinal tract or through the
skin, dissolve in the fat of serum, and come to steady
state with fat in tissues. Thus, fatty and nerve tissue
should be highest, most visceral organs intermediate,
muscle and bone lowest. Blood has a variable amount of
complex fat; the amount of PCB found in a serum
sample at a given time will depend on both "body
burden" and serum fat. Since excretion is very slow or
absent, acessation ofexternally administered dose does
not lead to lowered blood levels; the PCBs in serum fat
stay in steady state with stores in body fat. Large
weight losses should decrease the size of the compart-
ment but not the amount ofPCBs, thus levels should go
up. During lactation, fats are secreted but weight does
not change much; levels should go down.
There have been many investigations of PCBs in
blood, fatty tissue, or milk. In general, measurable
levels are ubiquitous, with the prevalence of positive
samples dependent on the sensitivity of the method
used; levels are highest among workers and consumers
of polluted sport fish (3). In some studies, blacks are
higherthan whites (13), males higherthan females, and
older people higher than younger (4). For simple
calibration purposes, consider a 25 year old lactating
woman weighing 60 kg. We expect aPCB concentration
of 1.8 ppm in the fact ofher milk; this is the median in
the 850 women in our North Carolina study of the
effects of PCBs on nursing children. If she is 20% fat,
she has about 22mgtotalbodyburden. She presumably
got this from background food contamination; spread
uniformly over her lifetime, this is 2.4 R,g/day. At her
current weight, this represents 0.04 pug/kg/day. If her
milk is 2% fat, she will have 36 ppb in whole milk. At
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0.5% fat, she will have about 9 ppb in serum; this is the
median in our data. Serum levels in the general popula-
tion range up to 60 ppb (3,4). Studies of workers have
found means of33 ppb (14), 37 ppb (15), 75 ppb (10) and
150-300 ppb (16).
To put this into toxicological perspective, the most
sensitive biologic phenomena thus far reported involves
the induction of microsomal enzymes of the P450 class
(17), or the covalent binding to macromolecules in
microsomes (an intermediate step in enzyme induction)
(18). Both occur in a dose related fashion beginning at
about 1 to 4 ,ug/kg/day. Decreased fertility and small
offspring were seen in experiments in which rhesus
monkeys were fed 2.5 ppm PCBs in the diet (about 100
,ug/kg/day). These monkeys had 33 ppm PCBs in their
adipose tissue near conception, and their milk later had
275 ppb or 16 ppm fat basis (19,20). Most other
experiments have been carried out at substantially
higher doses.
Placenta has very little fat, and in our data not much
PCB is detectable there. PCBs do cross the placenta,
and there are cases of congenital PCB poisoning (21).
Cord blood, however, is lower than term maternal blood
(22); this is due at least in part to the three-fold
difference in fat content.
The 5 kg infant of the hypothetical woman above
drinks 800 mL per day of milk; he gets 29 jig/day, or
about 6 ,ug/kg/day. This is substantially above any "safe"
level calculated forregulatory or advisory purposes; the
Allowable Daily Intake for PCBs as set by the Food and
Agriculture Organization is 1 ,ug/kg/day (23). Given the
available toxicity data, the possibility oftoxicity occur-
ringin breast fed children can not be ruled out on adose
basis alone. However, in general, breast-fed infants
thrive, and there are thus far no case reports ofillness
in a breast fed child attributed to PCBs at population
levels. There has not been an organized study oflevels
in breast milk in PCB workers. There are, however,
Japanese data that show that women who work around
PCBs have higher levels in their milk, that their
nurslings absorb and store the chemicals, and that
levels in children's sera are proportional to the duration
ofbreast feeding (15). In theJapanese Yusho epidemic,
Harada reports cases produced by breast milk exposure
alone (24), and there is suspicion of such cases in
Taiwan. Few samples of milk have been analyzed from
either outbreak; of those in the literature, the values
found are about the same as those in the Japanese
population (25).
Study of Human Reproduction
It is established that human beings are exposed to
PCBs, and that the compounds can disturb reproduc-
tive function. It is often difficult to show that such
dysfunction as occurs in a given group of people is
attributable toPCB oranyother exposure, however. We
will consider here the various reproductive outcomes
that are studied epidemiologically, some of the ways in
which they are studied, data on human studies ofPCBs
when available, and relevant laboratory data.
Fertility
There havebeennoformalstudies offertility dysfunc-
tion among humans exposed to PCBs. The suspicion
that the compounds are potentially active on human
fertility comes from experiments done on rhesus
monkeys, where a total diet containing 2.5 ppm PCBs
led to prolonged time to conception and fetal wastage
(19). The same study showed no changed in semen
characteristics ofthe male, or in the males' capacity to
reproduce.
Interest in the study of environmental effects on
humanfertilityisrelativelyrecent. Furthermore, epide-
miologic tools for measuring such effects have not yet
been well developed. Major effects of chemicals on
fertility have been detected more often by the affected
persons themselves than by epidemiologic research
(26,27).
Epidemiologic studies of fertility can compare vital
statistics datafrom populationgroups as awhole, orcan
compare groups using data obtained from individual
persons. Each approach has limitation.
The advantage ofthe vital statistics approach is that
birth certificate and census data are easily accessible.
By combining them one can calculate birth rates for
geographic areas such as states or countries. Although
one could link such data with population exposure
information, the birth rate by itselfis probably not very
sensitive to environmental factors. Other influences,
particularly contraceptive usage and desired family
size, probably overshadow the relatively small differ-
ences attributable to lowdose environmental exposures
to substances such as PCBs. In specific settings where
variation in PCB exposure is higher but where small
numbers of people are involved, the live birth rate is
unstable (that is, subject to wide chance fluctuations).
Whenindividuals areavailableforstudy, more specific
comparisons can be made of the rates of occurrence of
clinical infertility, or of the average time taken to
achieve pregnancy, live birth, or desired family size.
Contraceptive practices and other factors known to
affect the chance of conception can be accounted for in
design and analysis. This general approach has promise
forthe detection ofmore subtle effects on fertility, such
as might be expected from the low levels of PCB
exposure commonly seen. A few strategies ofthis kind
have been proposed (28,29), but none is yet well worked
out.
Semen analysis is ordinarily not performed unless
there is evidence of fertility impairment. The use of
semen analysis in the study ofenvironmental effects is
complicated by the fact that sperm can vary widely in
their characteristics without affecting fertility. Recent
development of sperm penetration assays, e.g., Karp,
(30) may refine the ability to detect toxic effects on
semen.
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Spontaneous Abortion
There are several cohorts of persons under observa-
tion who have been exposed to relatively high doses of
PCBs: capacitor factory workers in upstate New York
(31), insulation workers in Japan (22), and both Japan-
ese (32) and Taiwanese (33) families exposed to PCB-
contaminated heat exchange fluid in their cooking oil.
Thus far, none ofthese studies has shown a convincing
effect of PCBs on rates of spontaneous abortion.
However, the numbers of persons in these cohorts is not
large (all less than 2000), and as a consequence their
statistical power to show an effect is low.
Rhesus monkeys exposed to PCBs in concrete sealant
in their cages (34) or experimentally given PCBs at 2.5
and 5 ppm in the diet (19) had increased spontaneous
abortions and stillbirths. In both instances, however,
the female monkey had alopecia, erythema and edema
ofthe eyelids, and nonspecific metabolic abnormalities.
Thus, although it is clear that exposure to PCBs can
produce pregnancy loss, it is not clear that they will do
so at low doses not clinically toxic to the mother.
Spontaneous abortion among humans occurs in per-
haps 15% to 20% of recognized pregnancies. Even
though such loss is common, it is not easy to measure
epidemiologically. The occurrence of abortion can be
measured in one of two general ways. One is to collect
data on abortions that have occurred some time in the
past (retrospective data). The other is to collect data on
abortions at the time they occur (prospective data). By
using retrospective data, one can study much larger
numbers of abortions for a given population; however,
the quality of those data is poorer.
Retrospective spontaneous abortion data come from
either clinical records or personal interviews. Clinical
records are incomplete inthat not every woman whohas
a spontaneous abortion sees a doctor, or needs to. For
those women who do receive medical attention, the
event may be recorded in hospital records or clinic
records or private physicians' ifies in such a way that it
is not easily retrieved. This is especially true in the US,
where medical records are seldom usable as a primary
data source in the study of spontaneous abortion.
An alternative strategy for collecting retrospective
data is to interview the women themselves. Women's
recall of previous abortions is incomplete (35); further-
more, recall may be biased if women are alarmed about
their exposure to a potential toxin. The quality of such
abortion data can sometimes be improved by using
medical records to verify reported abortions. Recall
bias may be reduced in this way, and additional informa-
tion about the pregnancy may be obtained. This ap-
proach has been used in studies ofspontaneous abortion
among women who lived in areas sprayed with 2,4,5-T
and around the Love Canal (36). In general, this
retrospective approach may be the most suitable for
exploring possible pregnancy loss among PCB-exposed
women.
Prospective studies ofany exposed group are possible
but difficult, given the relative infrequency of preg-
nancy. Currentlyinthe USthere areabout sevenbirths
per year per 1000 women aged 15 to 44. The number of
observable pregnancies expected in a particular ex-
posed group would probably be so small as to make the
power ofthose observations limited.
Case-control studies of spontaneous abortion offer a
means ofcollecting data on a large number ofabortions
at the time they occur. However, linkingthose abortions
to exposure data is not easy. Unless the study popula-
tionisunusual, reported exposurestomostenvironmen-
tal agents will be rare. This method has worked for
furthering understanding ofcommon exposures such as
cigarettes, alcohol, and a few drugs, but its usefulness
is presumably less for the study ofPCBs, for which low
exposures are ubiquitous and high exposures are rare.
Fetal loss later in pregnancy is far less common than
spontaneous abortion but more accurately documented.
Most countries require pregnancy loss that occurs after
20 or 28 weeks of gestation to be registered as still-
births. Thus, studies of vital records comparing differ-
ences in late fetal loss between exposed and unexposed
groups are possible. However, the limitations ofuncon-
trolledconfoundersandunstableratesduetosmallnum-
bers make this an impractical approach under most
circumstances.
Birth Weight
In both of the recorded outbreaks of Yusho, babies
borntoaffectedmothersweresmallfortheirgestational
age (21). Studies to low-level exposure toPCBs onbirth
weight have been less definite than the observations of
Yusho mothers. One study reported higher levels of
PCBs in the mothers ofsmaller babies compared to the
mothers oflarger babies (37). However, this is not con-
sistentlyfound. Amonglaboratoryanimals, rhesusmon-
keys exposed to PCBs accidentally (34) or experimentally
(19,20) have been observed to produce small offspring.
Birth weight has several attractive features as an
endpointinthestudyofenvironmentalexposures. Birth
weight differs somewhat from the outcomes previously
discussed, inthatitisacharacteristic ofallbabiesrather
than an unusual outcome to be tallied. It is easy to
measure, itisrequiredonbirthcertificatesinmostcoun-
tries, it is plausibly an indicator ofintrauterine growth,
and for the individual infant it is the single strongest
predictor ofneonatal morbidity and mortality.
Birth weight is usually analyzed by comparing the
mean weights ofexposed and unexposed groups, or by
comparingthe occurrence oflow birth weight (less than
2500 grams) among groups. While such differences in
birth weight may be simple to establish, their inter-
pretation is not straightforward. The relation of birth
weight to mortality is such that a difference in mean
birth weight or low birth weight between groups does
notnecessarily meanthe groups differinmortality (38).
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Teratology
Commercial PCBs that have been in heat exchange
service are human teratogens (21,39). Affected babies
have been seen in the two Yusho outbreaks. Mothers
ingested cooking oil contaminated by the PCB mixture;
in most cases, mothers of affected babies were them-
selves obviously ill, and thus little detective work was
required. The full-blown syndrome is a small baby with
pigmented skin, conjunctivitis, pigmented gums, hypo-
plastic nails, metastatic scalp calcification, natal teeth,
comedones, and hyperbilirubinemia. Thus far, the syn-
drome has not been reported outside of the two
epidemics.
There are a variety of ways in which human terato-
gens have been studied. Typically, the notion that some
agent is teratogenic comes from a clinician, or some-
times a patient, who notices a cluster of some unusual
phenotype. Generally, specific congenital anomalies or
recognized syndromes of anomalies are rare events;
Down's syndrome, the commonest chromosomal anom-
aly and one of the more common syndromes recogniz-
able at birth, occurs in only 1/600 live births. There is a
great variety of anomalies, though, and the aggregate
rate of babies born with one is about 3-5%, counting
conditions like cystic fibrosis that were known to be
present at birth but diagnosed later. Because of the
rarity of individual conditions, the case-control ap-
proach seems tailor-made, yetitis not thatmuch harder
to surveyfor manyotherkinds ofcases whilewaitingfor
the ones of interest to be born. Examples of currently
used study designs are as follows.
RegistrylCohort. Patients with some specific ill-
ness,like diabetes mellitus (40), who are followed med-
ically anyway orpeoplewith exposuresofinterestunder
routine surveillance (like occupational cohorts) can be
followed for pregnancy outcome and any birth defects
noted. The attraction tothisisthatstructuralanomalies
are often very apparent at birth and easy to diagnose
and count. However, persuasive studies ofbirth defects
usually require either a very strong effect or very large
size. Most cohorts of workers are relatively small and
are not regularly producing malformed children at a
high rate; thus, the probability of detecting a terato-
genic exposure is small. The cohort method has worked
best in cases where the mothers themselves were ill,
as in Japan. Once the causal nature of the association
was clear, the occasional baby born with congenital Yu-
sho but with an unaffected mother could be recognized.
One'swishforthe etiologicclarityofepidemic situations
is tempered by the fact that they are typically public
health disasters; however, when they do occur, opor-
tunities for study should be exploited.
Surveillance. The US Centers for Disease Control
count all birth defects occurring in Atlanta that are
diagnosed by the time the child leaves the hospital.
Some information on the medical aspects of the preg-
nancy is also gathered. This program also surveys birth
defects as noted on discharge summaries in about 1/3 of
U. S. births. This system has proved useful for expedi-
tious confirmation or denial of hypotheses advanced
fromothersources, likePolandsyndrome andBendectin
(41). It is also good for monitoring secular trends, since
the problem ofpartial reportingis "cancelled out" when
the same data source is compared with itself over
time. Thus far, the system has not proved sensitive to
any occupational or specific environmental chemical
exposure.
Search forSyndromes. Babies are frequently born
with one ormore minoranomalies, such as mild midface
hypoplasia, hypoplastic nails, or other findings; such
children might not be called malformed at all except
under careful clinical scrutiny. Workers at the Univer-
sity ofWashington assembled such children, looked for
recurring clusters of anomalies, and inquired among
their parents about unusual exposures. It was in this
way that fetal dilantin (42) and alcohol (43,44) syn-
dromes were described. While the chain ofreasoning is
somewhat circular, hypotheses about the etiology of
such syndromes are readily tested by observing moth-
ers with the suspect exposure prospectively for the
specific findings in question. This approach would be
unlikely to incriminate a specific occupational exposure
ifcarried out in the general population, but it might be
useful to evaluate children in aprepaid clinic or HMO in
detail when many of the mothers worked around sub-
stances that might be teratogenic.
Case-ControlStudies. Studies ofobviousindividual
birth defects oretiologically similar kinds ofdefects are
done, typically when a cluster ofsome unusual anomaly
presents itself. Underthe best circumstances, thisis an
enormouslypowerfulapproach, asexploitedby McBride
for phocomelia and thalidomide (45) or Gregg for
congenital rubella (46). Actually, the designation case-
controlisabittooformalformanyoftheseobservations,
which often consist ofa case series with a frequency of
someexposurethatseems outoflinetotheinvestigator.
Lactation
PCBs in breast milk are ofinterest as an indicator of
exposure to the mother and a vector ofexposure to the
child. In addition, lactation performance is a plausible
endpoint for study because ofits implications for infant
development. In most developed countries, it is stan-
dard clinical practice to supplement or wean achild who
is ill or is failing to gain weight satisfactorily while
breastfeeding. Thus, subtle interference with the nutri-
tional orimmunologic activity ofbreast milkcould show
up as lactationfailure orshortened durationoflactation.
This phenomenon has no specific animal model; al-
thoughdairy cowsexposed topolybrominated biphenyls
(which differ from PCBs only in the substitution ofthe
halogen) in their feed dried up, this was part of a
general clinical syndrome and they were obviously ill
(47). In our data, women with higher levels of DDE do
not breast feed as lobig; this is not true of women with
higher levels of PCB (48).
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Development
Harada described lethargy and apathy and soft
meurological signs in children aged seven to nine who
had had Yusho years before (24). The growth defect in
these children, apparent at birth, was gone by about
age four. Formal developmental assessment of these
children has not been reported. However, in Michigan
farm children exposed to polybrominated biphenyls,
scores on a standardized school readiness scale (the
McCarthy Scales of Children's Abilities) were lower in
children with higher PBB body burden as measured by
analysis of fatty tissue (49,50). Rhesus monkeys ex-
posed to PCBs experimentally had abnormalities of
behavior (hyperactivity at first, hypoactivity at 44
months) and slowed development as measured by speed
on learning tasks (51,52). We are beginning to accrue
data on standard tests ofinfant behavior, development,
and school readiness (the Brazelton Neonatal Behav-
ioral Assessment Scale, the Bayley Scales of Infant
Development, and the McCarthy scales) in our project,
but analyses of them are not yet available.
Discussion
PCBs or chemicals like them could interfere with any
reproductive function discussed above if the dose were
to be high enough. The concern about toxicity to
reproductive function is that it might occur with no
overt signalthattoxiclevels had beenencountered -for
example, that an asymptomatic parent might poison a
child inadvertently. While no amount of negative data
can totally allay such a suspicion, there are certain
tactics that appear reasonable, as well as some com-
monly made suggestions that do not.
One belief or practice that does not bear scrutiny is
the emphasis on the reproductively active or pregnant
woman as the most sensitive to interference with
reproduction. It is biologically plausible to argue that
sperm cells, which undergo a more or less continuous
process ofmaturation throughout the male's life, are at
least as sensitive as the ovum, embryo or fetus. Thus
reproductively active males should share the same
concerns about workplace exposures as females. For
PCBs specifically, current US guidelines are that PCBs
be treated as carcinogens, which for practical purposes
means that exposures are limted to the lowest feasible
amounts in routine uses and applications. However,
nonroutine events, such as leaks and transport, should
be expected, so vigilance and prompt action are
required.
Various proposals involvingtesting ofbiological sam-
ples from workers have been made. Forexample, it has
been proposed that female workers have their milk
tested, and that those with levels above some specified
cutoff be advised not to breast feed. However, given
the very high prevalence ofdetectable background lev-
els, analysis of a sample in the absence of a specific
clinicalsuspicionofillnessisrarelywarranted. The most
likely outcome of such a test is a positive value that is
not readily interpretable. No quality control programs
exist for analytic procedures for such chemicals, and
there is evidence that labs vary substantially within
themselves and among each other on duplicate samples
(J. Liddle, U.S. Centers for Disease Control, personal
communication). There is no body of data that allows
clinical interpretation. Analysis is best done in a re-
search settingwhere results can be evaluated formally.
Failing that, it should be made clear in advance that
any sample will be likely to show a positive value, and
plans for dealing with questions that can be naturally
anticipated should be made in advance.
In terms ofresearch, we should exploit opportunities
to learn from unusual exposures or potential cases in
an epidemic, since this was the way in which much of
our current kniowledge was gained. Outside epidemics,
it seems likely that manifestations of toxicity will be
subtle, and only well-organized careful study, innova-
tive reasoning, and detailed clinical and chemical ob-
servation will pay off.
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